首页> 外文期刊>Revista de Gastroenterolog??a de M??xico >Outcomes of surgical treatment for patients with distal rectal cancer: A retrospective review from a single university hospital
【24h】

Outcomes of surgical treatment for patients with distal rectal cancer: A retrospective review from a single university hospital

机译:远端直肠癌患者的外科治疗结果:一所大学医院的回顾性审查

获取原文
           

摘要

Introduction and aimSurgery for distal rectal cancer (DRC) can be performed with or without sphincter preservation. The aim of the present study was to analyze the outcomes of two surgical techniques in the treatment of DRC patients: low anterior resection (LAR) and abdominoperineal resection (APR).MethodsPatients with advanced DRC that underwent surgical treatment between 2002 and 2012 were evaluated. We compared the outcomes of the type of surgery (APR vs LAR) and analyzed the associations of survival and recurrence with the following factors: age, sex, tumor location, lymph nodes obtained, lymph node involvement, and rectal wall involvement. Patients with distant metastases were excluded.ResultsA total of 148 patients were included, 78 of whom were females (52.7%). The mean patient age was 61.2 years. Neoadjuvant chemoradiation therapy was performed in 86.5% of the patients. APR was performed on 86 (58.1%) patients, and LAR on 62 (41.9%) patients. No differences were observed between the two groups regarding clinical and oncologic characteristics. Eighty-seven (62%) patients had pT3-4 disease, and 41 patients (27.7%) had lymph node involvement. In the multivariate analysis, only poorly differentiated tumors (P=.026) and APR (P=.009) correlated with higher recurrence rates. Mean follow-up time was 32 (16-59.9) months. Overall 5-year survival was 58.1%. The 5-year survival rate was worse in patients that underwent APR (46.5%) than in the patients that underwent LAR (74.2%) (P=.009).ConclusionsPatients with locally advanced DRC that underwent APR presented with a lower survival rate and a higher local recurrence rate than patients that underwent LAR. In addition, advanced T/stage, lymph node involvement, and poor tumor differentiation were associated with recurrence and a lower survival rate, regardless of the procedure.
机译:用于远端直肠癌(DRC)的介绍和Aimsurgery可以在没有括约肌保存的情况下进行。本研究的目的是分析治疗DRC患者的两种手术技术的结果:低前切除(LAR)和腹腔内切除(APS)。评估2002年和2012年期间的前医疗治疗的高级DRC的方法。我们比较了手术类型(APR vs LAR)的结果,并分析了对局部因素的生存和复发的关联:年龄,性别,肿瘤位置,淋巴结,淋巴结受累和直肠壁参与。患有远处转移的患者被排除在外。患者共有148名患者,其中78名是女性(52.7%)。平均患者年龄为61.2岁。在86.5%的患者中进行Neoadjuvant Chemoradiation疗法。 APR于86名(58.1%)患者,62名(41.9%)患者进行。两组之间的关于临床和肿瘤特征之间没有观察到差异。八十七(62%)患者患有PT3-4疾病,41名患者(27.7%)有淋巴结受累。在多变量分析中,只有差的肿瘤(P = .026)和APR(p = .009)与更高的复发率相关。平均随访时间为32(16-59.9)个月。总体5年生存率为58.1%。患有APR(46.5%)的患者比在患者(74.2%)(p = .009)中的患者中,5年生存率更差。与当地先进的DRC进行植物,植物患者患有较低的存活率和比患者更高的局部复发率。此外,无论手术如何,还与复发和较低的存活率相关,淋巴结受累和肿瘤分化差和较差的肿瘤分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号